Scailyte
AI platform analysing single-cell and spatial data to find disease-driving cell states for pharma partners in immune diseases
Highlights
- New on EvolcAdded 2026-10-21
About Scailyte
Scailyte is a precision medicine company that combines single-cell and spatial omics data with AI to identify disease-driving cellular states. Its ScaiVision platform uses supervised representation learning, along with generative and single-cell foundation models, and focuses on immune-mediated and inflammatory diseases.
Its IBD Flagship program is built on a single-cell and spatial dataset of inflammatory bowel disease, anchored by the Swiss IBD Cohort. Scailyte works with pharma partners on asset de-risking and trial stratification, target discovery and combination positioning, and co-developing predictive biomarkers and companion diagnostics. It also reports internal projects, including a tissue-based diagnostic partnered to Hera Biotech for global commercialisation.
The company is headquartered in Graz, Austria, and lists an address in Basel, Switzerland. The website cites 7 million single-cell profiles, 500+ patients and 1000+ samples in its IBD program.
Product: ScaiVision, an AI platform for discovering and translating disease-driving cellular states from single-cell and spatial omics data.
Jobs at Scailyte
More biotech & pharma companies
Haemo Pharma
Austrian pharma wholesaler and regenerative orthopaedics supplier for physicians, clinics and pharmaciesNew on EvolcSalary transparentoroboros.at
High-resolution respirometry instruments and DatLab software for mitochondrial research in labs and hospitalsRemote-friendlySalary transparentScancell
Clinical-stage immunotherapy developer for difficult-to-treat cancers, using Immunobody and Moditope platformsNew on EvolcSCellex
Spatial and bulk 3' RNA-seq tools and services for single-cell gene expression research in biotech and life sciencesNew on EvolcScreencell
Patented CTC isolation kits that enrich circulating tumor cells from whole blood for cancer researchers and laboratoriesNew on EvolcScripta Therapeutics
Drug discovery platform using transcription factor mapping and AI models to find neurodegenerative disease therapiesYoung companyNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Framer
